Is BridgeBio Pharma, Inc. an American company?
Yes — BridgeBio Pharma, Inc. is an American company.
BridgeBio Pharma, Inc. is incorporated in Delaware, United States and headquartered in Palo Alto, California. Its legal-entity record reports no foreign parent — the company is independently American-owned.
The evidence
- Legal name
- BridgeBio Pharma, Inc.
- Incorporated in
- Delaware, United States
- Registered office
- WILMINGTON, the United States
- Headquarters
- Palo Alto, California, United States
- Ultimate owner
- None reported (independent)
- Stock listing
- NASDAQ: BBIO on NASDAQ
- LEI
- 54930028YG89VTY2J114
Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters or stock listing does not always mean US incorporation — this page reports what the legal-entity registry actually records.
BridgeBio Pharma, Inc.: origin questions
Is BridgeBio Pharma, Inc. an American company?
Yes — BridgeBio Pharma, Inc. is an American company. BridgeBio Pharma, Inc. is incorporated in Delaware, United States and headquartered in Palo Alto, California. Its legal-entity record reports no foreign parent — the company is independently American-owned.
Where is BridgeBio Pharma, Inc. incorporated?
BridgeBio Pharma, Inc. is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.
Who owns BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.
Is BridgeBio Pharma, Inc. traded on a US stock exchange?
Yes — BridgeBio Pharma, Inc. trades under the ticker BBIO on the NASDAQ.
See the full BridgeBio Pharma, Inc. company profile — financials, stock data and trust credentials — or browse the directory of American companies.